Discovery and Identification of a Novel Human Monoclonal Neutralizing Antibody Targeting Domain Ⅰ of Severe Fever With Thrombocytopenia Syndrome Virus Gn
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.71111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Lin Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Medical and Pharmaceutical University, Yantai, China. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Antibodies, Neutralizing, Phlebovirus, Severe Fever with Thrombocytopenia Syndrome. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Shandong Province, Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province.
Abstract (Originalsprache)
Severe fever with thrombocytopenia syndrome virus (SFTSV) is a tick‐borne pathogen that causes severe fever with thrombocytopenia syndrome and posed a severe threat to public health. Our study panned and screened the phage‐display antibody library constructed from the peripheral blood mononuclear cell (PBMC) from three SFTSV‐infected convalescent patients. Human monoclonal antibodies (hmAbs) targeting SFTSV glycoprotein N (Gn) were isolated from the library and evaluated for binding, affinity, and neutralizing activities in vitro. Epitope identification was performed by structural model analysis, immunofluorescence and RT‐qPCR. The results showed that hmAb B36 is a Gn‐binding, moderately high affinity, neutralizing antibody. Moreover, hmAb B36 recognizes a conformational epitope formed by six residues on the domainⅠof the SFTSV Gn, which differs from the epitope previously reported. Among these residues, G114, L155, and S158 were identified as key sites for hmAb B36‐mediated recognition. This study performed isolation and identification of a novel neutralizing antibody, offering insights for the future development of therapeutic antibody cocktails and vaccines against SFTSV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Medical and Pharmaceutical University, Yantai, China.
- Yantai Qishan Hospital, Yantai, China.
ORCID-Profile: Yuanyuan Qiao
Förderung
- Natural Science Foundation of Shandong Province
- Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province
Zitieren
APA
Wang, L., Liu, Y., Zhang, L., Xu, J., Dong, Z., Yang, L., Cao, W., Liu, C., Li, J., & Qiao, Y. (2026). Discovery and Identification of a Novel Human Monoclonal Neutralizing Antibody Targeting Domain Ⅰ of Severe Fever With Thrombocytopenia Syndrome Virus Gn. Journal of Medical Virology. https://doi.org/10.1002/jmv.71111
Vancouver
Wang L, Liu Y, Zhang L, Xu J, Dong Z, Yang L, et al. Discovery and Identification of a Novel Human Monoclonal Neutralizing Antibody Targeting Domain Ⅰ of Severe Fever With Thrombocytopenia Syndrome Virus Gn. Journal of Medical Virology. 2026. doi:10.1002/jmv.71111
BibTeX
@article{Wang2026,
author = {Wang, Lin and Liu, Yuanni and Zhang, Lei and Xu, Jiaxin and Dong, Zhouyan and Yang, Lilan and Cao, Weiyou and Liu, Chengxuan and Li, Jiayu and Qiao, Yuanyuan},
title = {Discovery and Identification of a Novel Human Monoclonal Neutralizing Antibody Targeting Domain Ⅰ of Severe Fever With Thrombocytopenia Syndrome Virus Gn},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71111}
}
EUVIMED